Rosen, a top ranked law firm, encourages cerevel therapeutics holdings, inc. investors to secure counsel before important deadline in securities class action - cere

New york, april 25, 2025 (globe newswire) -- why: rosen law firm, a global investor rights law firm, reminds persons or entities that (1) sold or otherwise disposed of the publicly-traded common stock of cerevel therapeutics holdings, inc. (nasdaq: cere) during the period from october 11, 2023 through august 1, 2024, inclusive (the “class period”); (2) held shares of cerevel as of the january 8, 2024 record date and were entitled to vote on the merger of cerevel and abbvie inc.; and/or (3) sold shares of cerevel stock contemporaneously with bain capital's purchase of shares on or about october 16, 2023, of the important june 3, 2025 lead plaintiff deadline.
TOP Ratings Summary
TOP Quant Ranking